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Abstract: The Liverpool Epidemic Strain (LES) is an important transmissible clonal lineage of
Pseudomonas aeruginosa  that chronically infects the lungs of people with cystic
fibrosis (CF). Previous studies have focused on the genomics of the LES in a limited
number of isolates mostly from one CF centre in the UK, and from studies highlighting
identification of the LES in Canada.  Here we significantly extend the current LES
genome database by genome sequencing 91 isolates from multiple CF centres across
the UK, and we describe the comparative genomics of this large collection of LES
isolates from the UK and Canada.
Phylogenetic analysis revealed that the 145 LES genomes analysed formed a distinct
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clonal lineage when compared with the wider  P. aeruginosa  population.  Notably, the
isolates formed two clades: one associated with isolates from Canada, and the other
associated with UK isolates.  Further analysis of the UK LES isolates revealed
clustering by clinic geography.  Where isolates clustered closely together, the
association was often supported by clinical data linking isolates or patients. When
compared with the earliest known isolate, LESB58 (from 1988), many UK LES isolates
shared common loss of function mutations, such as in genes  gltR  and  fleR  , Other
loss of function mutations identified in previous studies as common adaptations during
CF chronic lung infections were also identified in multiple LES isolates. Analysis of the
LES accessory genome (including genomic islands and prophages) revealed variations
in the carriage of large genomic regions, with some evidence for shared genomic
island/prophage complement according to clinic location. 
Our study reveals divergence and adaptation during the spread of the LES, within the
UK and between continents.
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The Liverpool Epidemic Strain (LES) is an important transmissible clonal lineage of 2 
Pseudomonas aeruginosa that chronically infects the lungs of people with cystic fibrosis 3 
(CF). Previous studies have focused on the genomics of the LES in a limited number of 4 
isolates mostly from one CF centre in the UK, and from studies highlighting identification of 5 
the LES in Canada.  Here we significantly extend the current LES genome database by 6 
genome sequencing 91 isolates from multiple CF centres across the UK, and we describe the 7 
comparative genomics of this large collection of LES isolates from the UK and Canada. 8 
Phylogenetic analysis revealed that the 145 LES genomes analysed formed a distinct clonal 9 
lineage when compared with the wider P. aeruginosa population.  Notably, the isolates 10 
formed two clades: one associated with isolates from Canada, and the other associated with 11 
UK isolates.  Further analysis of the UK LES isolates revealed clustering by clinic 12 
geography.  Where isolates clustered closely together, the association was often supported by 13 
clinical data linking isolates or patients. When compared with the earliest known isolate, 14 
LESB58 (from 1988), many UK LES isolates shared common loss of function mutations, 15 
such as in genes gltR and fleR, Other loss of function mutations identified in previous studies 16 
as common adaptations during CF chronic lung infections were also identified in multiple 17 
LES isolates. Analysis of the LES accessory genome (including genomic islands and 18 
prophages) revealed variations in the carriage of large genomic regions, with some evidence 19 
for shared genomic island/prophage complement according to clinic location.   20 
Our study reveals divergence and adaptation during the spread of the LES, within the UK and 21 
between continents. 22 
 23 
Impact statement 24 
Chronic lung infections caused by Pseudomonas aeruginosa are the major cause of the 25 
morbidity and mortality associated with cystic fibrosis.  In the United Kingdom and Canada, 26 
a particular lineage of P. aeruginosa (the Liverpool Epidemic Strain, or LES) possesses 27 
unusual characteristics: it can transmit between patients and is associated with greater 28 
morbidity.  In the UK, the LES lineage is the most common lineage found amongst CF 29 
isolates.  Using whole genome sequencing and comparative genomics analyses, we analysed 30 
145 LES isolates from across the UK and Canada, providing the most comprehensive 31 
analysis to date of the LES lineage.  We demonstrate geographical clustering of LES isolates, 32 
and describe how the lineage has adapted and diverged.  In particular, we show divergence 33 
between isolates in Canada compared to the UK, and variations between isolates from 34 
4 
 
different UK clinics.  Our analysis has identified adaptations that might contribute to the 35 
success of this lineage as a pathogen in cystic fibrosis. 36 
 37 
 38 
Data summary 39 
The Genbank accession numbers of the genomes used in this study that have previously been 40 
deposited in the National Centre for Biotechnology Information (NCBI) database, along with 41 
the published studies they were analysed for have been provided in Supplementary table 1. 42 
Genomes sequenced for this study have been deposited in the NCBI Genome database under 43 
the BioProject ID: PRJNA615626 and their accession numbers are provided in 44 
Supplementary table 1.  45 




Chronic lung infections with the versatile pathogen Pseudomonas aeruginosa remain the 48 
major cause of morbidity and mortality associated with Cystic Fibrosis (CF). During the 49 
infection process in the CF lung, the bacterium undergoes characteristic adaptive changes (1), 50 
making it difficult or impossible to eradicate once established.  Because P. aeruginosa can 51 
prosper in a wide variety of environmental and clinical niches, exposure to it is inevitable, 52 
and it is still a wide assumption that the majority of CF patients acquire their infections from 53 
an environmental source.  However, it has become clear that specialist clones of P. 54 
aeruginosa capable of patient-to-patient transmission exist (2,3), leading to over-55 
representation amongst isolates from CF.  The occurrence of such strains presents additional 56 
challenges in terms of patient care, but their identification does enable steps to be taken to 57 
minimise transmission amongst patients (4).  One of the best studied transmissible clones is 58 
the Liverpool Epidemic Strain (LES), first discovered in a children’s CF Unit in Liverpool 59 
(5), but since identified as the most common single clone amongst CF isolates from patients 60 
in the UK (6).  The LES lineage has also been identified in Canada (7,8).  The LES has a 61 
number of important characteristics, including the ability to superinfect (9), increased 62 
production of some virulence factors (10,11), an association with increased morbidity (12),  63 
increased resistance to antimicrobials (13), and the ability to cause infections beyond the CF 64 
host, including infections of the non-CF parents of a CF patient (14) and a patient’s pet cat 65 
(15).  The strain has also been reported as causing pleural empyema in a CF patient (16) and 66 
has been isolated from patients with primary ciliary dyskinesia and non-CF 67 
bronchiectasis(unpublished data).  68 
Since the first P. aeruginosa genome was published in 2000 (17), a number of other complete 69 
P. aeruginosa genomes have been made available (18–24).  Whole genome sequence data 70 
has also been used for analyses of within clone variation for the two most abundant P. 71 
aeruginosa clones globally (PA14 and Clone C) (25). The complete genome of the earliest 72 
known LES isolate (LESB58 from 1988) was published in 2009 (26), revealing a number of 73 
genomic features, including five genomic islands and six prophages, some of which have 74 
been implicated in the competitiveness of the strain in vivo (26,27), and five of which can be 75 
detected as free phages in CF patient sputa (28). Since then, three further genomes from LES 76 
isolates from Liverpool (29) and 12 from Ontario, Canada (8) have been reported.  In 77 
addition, further LES isolate genomes have been sequenced from the adult CF unit in 78 
Liverpool in studies suggesting the co-existence within patients of distinct LES sub-lineages 79 
(30–32).   80 
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The aim of this study was to determine the genome sequences of a larger collection of LES 81 
isolates from multiple centres throughout the UK and analyse the resulting extended dataset 82 
in order to characterise the diversity of a major CF transmissible strain in the context of 83 
geographical and temporal dissemination. Our data support the sub-division of LES isolates 84 
into distinct UK and Canadian clades with some additional clustering by centre within the 85 
UK and reveal mutational signatures of on-going adaptation to the CF lung environment.  86 
Methods 87 
Bacterial Strains  88 
Details of all the LES isolates included in genomic analysis are given in Table S1.  In total, 89 
145 LES genomes were analysed, including the genomes of 91 isolates sequenced for this 90 
study. The majority of the newly sequenced isolates were obtained from the collection at 91 
Public Health England (PHE), Colindale or the archived collection in Liverpool. Additional 92 
UK genomes were obtained from CF centres in the West Midlands and East Midlands.  93 
Amongst the published genomes included were representatives of different sub-lineages of 94 
the LES identified in a study of isolates in the Liverpool Adult CF Unit (30).  95 
Genome sequencing of bacterial isolates 96 
DNA was extracted from 91 LES isolates using the Promega Wizard genomic DNA 97 
extraction kit. Whole genomes were sequenced either by the Centre of Genomic Research 98 
(CGR), Liverpool, using Nextera library preparation and an Illumina HiSeq sequencer or at 99 
Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Canada on the 100 
Illumina MiSeq platform. An additional 54 previously published LES genomes were included 101 
in the analysis (8,29,30).  These included a re-sequenced strain LESB58, labelled as genome 102 
LESB58_2. 390 non-LES P. aeruginosa genomes were obtained from a published P. 103 
aeruginosa genomics study (23) to represent a wider P. aeruginosa population set. 104 
Genome assemblies 105 
Short reads were adapter trimmed and quality filtered using cutadapt-1.9.2 (33) and 106 
assembled to the contig level using the A5 assembly pipeline (34).  The de novo assembled 107 
contigs were scaffolded to the genome of LESB58 (26) using ABACAS (35). Contigs 108 
containing sequence accessory to the LESB58 genome were appended to the end of each 109 
draft genome. All genomes were annotated with Prokka-1.12, including CRISPR prediction 110 
(36). The pseudomonas.com database (37) was used to facilitate further assessment of gene 111 
function and the impact of mutations. Multi locus sequence types (MLSTs) were determined 112 




Core genome phylogeny 115 
In order to assess the placement of the LES lineage in the wider P. aeruginosa population a 116 
relaxed core P. aeruginosa tree was inferred from the LES genomes and the 390 P. 117 
aeruginosa genomes from a previous genomics study (23). LESB58 was designated as the 118 
initial reference genome for Panseq (39), followed by random successive reference selection 119 
for genomic regions not present in previous reference genomes. Successive reference 120 
genomes were split into 500 bp fragments and pairwise aligned to all other genomes. 121 
Fragments with at least 90% BLAST percent identity to the reference in 95% of taxa 122 
(508/535) were designated as belonging to the relaxed core, aligned with clustalW (40) and 123 
concatenated with SCaFoS (41). The resulting 5,517,752 bp supermatrix contained 429,463 124 
informative sites. The tree was inferred by maximum likelihood (ML) with the HKY85 125 
substitution model and 1000 ultrafast bootstrap (UFBoot) (42) replicates for branch support 126 
using IQ-TREE-1.6.2 (43). To assess the root position of the LES lineage this was repeated 127 
with the 145 LES genomes and P. aeruginosa reference genomes and known outgroups: 128 
PAO1 and PA14 (17,44). Fragments were defined as core if they had 90% BLAST percent 129 
identity with the reference and were present in 95% of taxa (141/147). This resulted in a 130 
5,840,172 bp relaxed core supermatrix including 14,730 informative sites. The TIM+R5 131 
substitution model was determined as the best fit for the data by IQ-TREE (43) model test 132 
(45) and the phylogenetic tree was inferred by ML with 1000 UFBoot replicates where at 133 
least 95% confidence is recommended as well supported. The tree was rooted between 134 
outgroups PAO1 and PA14 and the rest of the tree. Finally, snippy 135 
(https://github.com/tseemann/snippy) was used with default parameters to generate a 136 
substitutions only LES core SNP alignment from all LES assemblies and the tree was 137 
approximated using runListCompare (https://github.com/davideyre/runListCompare) which 138 
uses IQ-TREE (43) for model selection and phylogeny inference and ClonalFrameML (46) 139 
for the identification of recombinant sites to be removed from the alignment. LESB58 140 
genomic island and prophage regions (26) were also masked. The GTR+F+G4 substitution 141 
model was selected by IQ-TREE and there were 2,947 informative sites. Phylogenetic trees 142 
were visualised with either the interactive tree of life software (iTol) (47) or GrapeTree (48). 143 
SNP distances were plotted using python packages seaborn (https://seaborn.pydata.org/), 144 
matplotlib (49), pandas (50), numpy (51) with the Jupyter Notebook environment (52).  145 
 146 
Core and accessory genes 147 
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The core and accessory gene content of the LES genomes was determined by Roary (53) 148 
using Prokka annotated gff files as input and without splitting paralogs. This was repeated for 149 
the LES plus the wider P. aeruginosa population genomes but with paralog splitting. Genes 150 
determined to be ‘strict core’ in the pangenome analysis by Roary were present in >=99% of 151 
the total set and relaxed core >=95%. Association tests of accessory gene content and 152 
Benjamimi-Hochberg (BH) multiple testing corrections were performed by SCOARY (54) 153 
using the Roary generated gene presence/absence matrix output as input. Abricate 154 
(https://github.com/tseeman/abricate) was used to investigate the potential presence of 155 
antibiotic resistance conferring genes. 156 
Structural analysis  157 
The assembled genomes were also compared to LESB58 for large, structural differences 158 
using the Blast Ring Image Generator (BRIG) (55) to identify large (10 kb or greater) 159 
deletions. The presence and absence of virulence genes in the assembled genomes was 160 
investigated using Blastable v0.4, a Python script (https://github.com/bawee/blastable) that 161 
performs a nucleotide BLAST+ search. To further investigate the presence and absence of 162 
LESB58 prophages and genomic islands a database of LES genomes was generated using 163 
BLAST+ (56) makeblastdb against which each LESB58 prophage and genomic island was 164 
aligned using BLAST+ blastn (window size 28). Percent identity was corrected for the 165 
contribution of duplicate regions present elsewhere in the draft genome by reciprocally 166 
aligning known duplicate regions with blastn (28). 167 
Identification of SNPs and microindels in UK LES relative to the genome of LESB58 168 
High quality SNPs and microindels in the UK LES genomes for which short reads were 169 
available were called against the completed LESB58 reference genome, which is the 170 
outgroup to the UK LES and the oldest dated LES isolate (26,30). Quality filtered short reads 171 
were mapped to reference genome LESB58 with bwa0.7.5a mem (57). The LESB58 genome 172 
(.fasta) was indexed with bwa-0.7.5a index (57) and samtools-0.1.18-r580 (58) faidx. A 173 
sequence dictionary was created with picard-tools-1.135 (59) -CreateSequenceDictionary. 174 
The resulting sequence alignment map (.sam) file from read mapping with bwa was 175 
converted to a binary alignment map (.bam) file using picard-tools SortSam. Duplicates were 176 
marked using picard-tools MarkDuplicates and a bam file index created with picard-tools 177 
BuildBamIndex. The Genome Analysis Toolkit-3.4 (GATK) (60) Realignor Target Creator 178 
was used to designate targets for indel realignment and indels were realigned with GATK 179 
IndelRealigner. Variants were called using GATK HaplotypeCaller (-ploidy 1-180 
emitRefConfidence GVCF) to produce a variant call (.vcf) file prepared for genotyping. The 181 
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vcf file was genotyped using GATK GenotypeGVCFs and filtered using vcffilter (61) basic 182 
filtering (DP >9 and QUAL >10). Variant annotation was performed by snpEff-4.1l (62) with 183 
the default parameters for GATK output (-eff -gatk) to the LESB58 reference genome 184 
annotation database, uid59275. Additionally, we determined whether genes had larger 185 
deletions not detectable due to lack of sequencing reads and absence of genomic context in 186 
vcf files. First bam files were indexed with samtools index and the reads aligned to a regions 187 
determined by snpEff database gene regions using samtools depth. Genes with any deletions 188 
larger than 20bp were not considered for parsimonious assessment of convergent adaptation 189 
by loss of function.  190 
Results 191 
Genome assemblies 192 
A geographically and historically diverse sample of LES isolates was selected for this study 193 
(n = 91) and was combined with a set of previously sequenced LES genomes (n = 54). The 194 
newly sequenced genomes were primarily isolated from CF patients, but also included some 195 
isolates from primary ciliary dyskinesia (PCD) patients, a pet cat (OSIRIS) (63), non-CF 196 
bronchiectasis (nCFBr) patients, a blood isolate (PHELES19) and the non-CF parents of a CF 197 
patient (14). All LES genomes analysed in this study, their geographic source (according to 198 
PHE regions) and date of isolation, if known, are presented in Table S1. The mean number of 199 
CDS per genome was 6,004, with a range of 5,854 (PHELES12) to 6,506 (JD324). Nearly all 200 
LES genomes, with the exception of those from isolates prefixed with ‘JD’, and ‘MdLES’, 201 
were predicted to carry type 1 CRISPR sequences.  202 
The LES genomes form a distinct lineage amongst the wider P. aeruginosa population 203 
A relaxed core genome was extracted from a combination of all the LES genomes plus the 204 
wider P. aeruginosa population set. The LES was resolved as a monophyletic, clonal lineage 205 
(Figure 1). The lineage is comprised of two MLST sequence types, ST-146 (primarily) and 206 
ST-683, that differ in the ppsA locus. Of the 145 LES genomes, 128 were ST-146, two were 207 
ST-683 and 15 didn’t correspond to known ST’s, differing from ST-146 by one locus in each 208 
case. The wider tree largely resolved into two major P. aeruginosa phylogenetic groups but 209 
with a few lineages being placed in neither of the major groups, consistent with previous 210 
analysis (64). One genome from the wider population set was placed within the LES clade, 211 
namely isolate AZPAE13757_2337, associated with a respiratory tract infection (RTI) from 212 
Canada. This isolate also carries the LES serotype (06) and MLST (ST-146) and was 213 
therefore coded as LES in the gene association analysis (23).  214 
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A tree of the LES genomes included in this study, with additional genomes from the 215 
reference strains PAO1 and PA14, was reconstructed based on a relaxed core genome 216 
fragments supermatrix. The LES genomes clustered into two major phylogenetic groups, with 217 
clade I containing mainly Canadian isolates and clade II containing entirely UK-sourced 218 
isolates. The root position was determined with 100% UFBoot support to be within clade I 219 
(Supplementary figure 1).  220 
Phylogenetic analysis reveals clustering by clinic geography 221 
The LES reference genomes representing the oldest known LES isolate, LESB58 (whole 222 
genome) and LESB58_2 (re-sequenced with Illumina data, 2.93 SNPs different) were placed 223 
between the two clades, and thus represented an outgroup to the rest of the UK genomes 224 
(Figure 2). There were two main exceptions to the general rule of separation according to 225 
country of origin. Clade I contained two LES isolate genomes sampled from the UK: LiP6 226 
and PHELES19. Further investigation revealed that the patient infected with LiP6 had lived 227 
in Canada, but no further information was available for the patient infected with PHELES19, 228 
other than the fact that this was a blood isolate. Within clade II there was phylogenetic 229 
evidence for further clustering by source of isolation within the UK and between patients 230 
known to be in contact with one another. Where genomes from one region or clinic were 231 
placed within a UK sub-clade dominated by genomes from a different clinic or region, further 232 
information was sought about possible previous patient links to the region. PHELES10 and 233 
PHELES16 were isolated from patients in the East of England in 2014 but fall within a 234 
majority East Midlands clade. Both patients were recorded as attending and presenting 235 
samples prior to 2014 in the East Midlands CF Unit. PHELES1 was isolated from a patient in 236 
Scotland but falls within a majority East Midlands clade; this patient had previously attended 237 
the East Midlands CF clinic. Although many sub-clades of the LES had a clear geographical 238 
association (Figure 2), there were some examples of isolates from different origins clustering.  239 
For example, isolates PHELES20, 4, 15, 12 and 23 cluster together despite being from 240 
different geographical locations. However, we do not have sufficient information about 241 
patient histories to explain this..  242 
 243 
The LES tree was corrected for recombination after likely recombinant regions were detected 244 
in 30 inner nodes of the tree and 109 tip-branches (Figure 2). Within clade I the median 245 
recombination corrected pairwise branch length (193.92 SNPs) was longer than within clade 246 
II with (119.72 SNPs) including LESB58 (Supplementary figure 2; Supplementary figure 247 
3A). The longer clade I branch lengths could either be due to the lineages being older, sparse 248 
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sampling or that the clade II genomes by comparison have transmitted faster. Overall, the 249 
median branch lengths within the LES tips were 131.11 SNPs (of 10,440 exclusive pairs). 250 
Phylogenetic analysis reveals clustering supported by clinical history 251 
Individual CF patients (identified as isolates that are designated with names commencing 252 
with “CF” followed by a common number, for example CF5S120, CF5S138 and CF5S134, 253 
all from patient CF5) typically clustered together. In a previous study by Williams et al.(30) 254 
with extensive within patient sampling within a single CF clinic it was possible to determine 255 
that there were coexisting distinct lineages of the LES within individual patients. The 256 
coexistence of divergent lineages within patient ‘CF3’ were further confirmed here with two 257 
separate clusters (one containing CF3S124, CF3S235, CF3S224 and CF3S108; the other 258 
containing CF3S25, CF3S219 and CF3S225). The branch length between randomly selected 259 
genomes from each cluster, CF3S235 and CF3S219 was 108 SNPs.  260 
The shortest branch lengths were most often between within-patient samples, though some 261 
branch lengths for isolates from different patients were shorter than between within-patient 262 
isolates, suggesting recent transmission or conversely distinct coexisting lineages within 263 
patients (Supplementary table 2). The shortest branch lengths from within-patient samples 264 
were SED11/SED20 SED1/SED11, SED1/SED20 (32,65), with 0, 3.9 and 3.9 SNPs 265 
respectively and CF9S124/CF9S111 with 0.97 SNPs. Conversely between-patient isolate 266 
genomes also had smaller branch lengths than some within-patient lineage branch lengths. 267 
These included 49492/30567S with 21.41 SNPs, 72G/B35 with 18.48 SNPs and 268 
PHELES27/PHELES29 with 10.69 SNPs.  269 
There were a number of examples where isolates clustering together were linked based on 270 
clinical data. For example, isolates 139124 and 139125 (103.2 SNPs) from a single PCD 271 
patient, and isolate 119579 from their sibling (81.78 SNPs to 139125), also a PCD patient, 272 
were adjacent on the tree. Isolates PHELES27 and PHELES29 (10.7 SNPs), and isolates 273 
89204 and 89212 (82.7 SNPs), were isolated from siblings. Isolate CFS120 was from a CF 274 
patient and clustered with 417GLY (71.1 SNPs), isolated from their non-CF parent (63). The 275 
isolate OSIRIS, isolated from a pet cat, clustered with the human isolate 89568 (28.21 SNPs), 276 
isolated from the owner. Isolates 79426 and 79427 (166.6 SNPs), from the same empyema 277 
patient, clustered together.   278 
Although many sub-clades of the LES had a clear geographical association (Figure 2), there 279 
were some examples of isolates from different origins clustering. For example, isolates 280 
PHELES20, 4, 15, 12 and 23 cluster together despite being from different geographical 281 
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locations. However, we do not have sufficient information about patient histories to explain 282 
this.  283 
The LES accessory genome 284 
The gene content for all LES genomes in this study (the LES pangenome) was compared with 285 
the pangenome of the wider P. aeruginosa population set. To assess significant associations 286 
between genes and designated groups of either the LES or the wider population set, the 287 
Fishers exact test (<.05) was used and Benjamimi Hochberg (BH) correction for multiple 288 
testing (54). A pangenome with 535 genomes, including the 145 LES genomes, was 289 
constructed. There were 3,251 strict core genes (present in >=99% genomes) of a pangenome 290 
of 33,033 different genes (where paralogous groups within the same genome were classified 291 
as the same gene). Compared with the wider population set there were 2,922 genes 292 
significantly associated with the LES by absence and 1,397 genes significantly associated 293 
with the LES by presence. There were 152 genes present in >=95% of the LES genomes but 294 
<=10% of the wider population. Of these 108 are located within LESB58 genomic islands or 295 
prophages, particularly LES GI-3 (48 genes), LES prophage 3 (25 genes), LES prophage 4 296 
(17 genes) and LES GI-1 (15 genes) (Supplementary table 3). There were 22 genes that were 297 
present in >=95% of the wider population and <=10% of the LES (Supplementary table 4).  298 
We conducted further analyses to identify large regions that were absent from some LES 299 
isolate genomes. We interrogated the LES genomes using abricate in order to seek evidence 300 
for horizontal acquisition of antibiotic resistance genes. In addition to identifying resistance-301 
related genes common to all isolates, there was evidence for additional beta-lactamase genes 302 
in several isolates. In particular, isolates from three different CF patients (CF3S108, 303 
CF4S132 and CF7S115) harboured class A beta-lactamase TEM-181 genes sharing 100% 304 
identity with a gene in E. coli (Accession number NG_050218.1). This gene was not carried 305 
by other LES isolates from the same patient sputum samples.  306 
Deletions of more than 10 kb were present in 24 of the LES sequenced genomes 307 
(Supplementary figure 4; Supplementary table 5). Twenty eight deletions were identified, 308 
with seven of the deletions being greater than 100 kb, and the largest being 249 kb. CF9S111 309 
and CF9S124 contained the same deletion, consistent with their high sequence similarity and 310 
adjoining positions on the phylogenetic tree (Figure 2); the same is true of JD304 and 311 
LESlike1. Most strains contained only one deletion although four strains contained two. The 312 
deletions were non-randomly distributed in the genome, with 15 of the 24 strains having 313 
deletions in the region between 3.10 and 3.50 Mb (Supplementary figure 4). This region of 314 
the LESB58 genome contains, amongst others, genes encoding an extracellular 315 
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polysaccharide (Psl), a siderophore (pyoverdine) and a Type VI secretion system 316 
(Supplementary table 6). 317 
There were also variations in the carriage of previously reported (26) LES genomic islands 318 
(GIs) and prophage regions (Figure 2).  LES prophage 5 was more commonly absent from 319 
the LES isolate genomes.  Carriage of prophage 2 and GI5 was also highly variable, with 320 
some evidence for shared GI/prophage complement according to geographical regions 321 
(Figure 2).  For example, the absence of GI5 was a feature of isolates from the East Midlands 322 
region.  Likewise, there is a cluster of isolates from the Liverpool region that lack LES 323 
prophages 2 and 5.  All of the isolates from Canada lacked LES prophage 5, but there were 324 
variations with respect to both carriage and divergence for other GI and prophage regions 325 
(Figure 2).  326 
Mutations in LES genomes 327 
Genomes of clade II (entirely UK-sourced) isolates for which short reads were available for 328 
high quality read mapping and variant calling (n = 124) were assessed for mutations 329 
compared with the oldest known LES isolate LESB58 (from 1988), as reference and 330 
outgroup to the clade II LES. There were 19,679 variants counted across all UK LES 331 
compared with LESB58, including 10,036 different mutations in 3,742 different genes. The 332 
majority of variants by mutational impact category were amino acid substitutions (54.94%),  333 
followed by synonymous nucleotide substitutions (20.24%), frame-shifting mutations 334 
(9.96%), mutations upstream of coding regions (9.56%) and premature stop codons gained 335 
(2.60%).  The remainder (2.69%) comprised codon insertions, codon deletions, codon 336 
changes plus insertions, mutations downstream of coding regions, stop codon loss, start 337 
codon loss, synonymous stop codon substitution and non-synonymous start codon 338 
substitutions. The majority of different mutations (7,507/10,036) were present only in one 339 
genome. 106 of the different mutations were present in ten or more genomes, including 34 340 
carried in each of 100 or more genomes. Mutations in or upstream of twenty different genes 341 
were found in all 124 UK LES genomes relative to LESB58 (Supplementary table 7).  Two 342 
of these were synonymous mutations (in phuR and wbpY), and two were located upstream of 343 
genes.  The remaining 16 were amino acid substitutions in genes, including in the nosR gene, 344 
encoding  a regulatory protein. It is possible that in these cases, LESB58 is the isolate that has 345 
acquired a mutation. However, the genome of LESB58 is identical to strain PAO1 in the 346 
region of the nosR mutation, and the mutation identified is not present in any of the Canadian 347 
LES, suggesting that it is a genuine mutation relative to LESB58 in all the UK LES isolates. 348 
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The reported 14 bp deletion in gltR, previously believed to be fixed in UK LES genomes 349 
other than LESB58 (29) was present in 100/124 UK LES genomes. Of the 24 UK isolates not 350 
harbouring this deletion, all but one (CF54NCTC13415) were associated with a majority East 351 
Midlands cluster (from isolate 10333 to isolate SED1 on the tree in Figure 2). This mutation 352 
is not present in any of the Canadian LES.  A nonsense mutation in fleR, also not found 353 
amongst the Canadian isolates, was present in 122/124 UK LES genomes (Supplementary 354 
table 7). An additional isolate (8835) carried a 28 bp deletion in fleR spanning the same locus 355 
of the nonsense mutation.  LiP1a was the only isolate genome analysed without a nonsense 356 
mutation in fleR. However, the closely related LiP1c, isolated from the same patient as LiP1a, 357 
did harbour the nonsense mutation in fleR (Figure 2; Supplementary table 7). 358 
 359 
There were more non-synonymous mutations in some genes than others, suggesting ongoing 360 
adaptation as the strain spread around the UK. The majority of different genes carrying a 361 
nonsense mutation represented a single acquisition (615/742), including those present in only 362 
one isolate genome. The remaining 127 different genes were inferred to have independently 363 
acquired nonsense mutations in the population between 2 and 32 times. Those with four or 364 
more independent acquisitions in the population are displayed in Table 1, and include genes 365 
associated with functions such as antibiotic resistance, quorum sensing, mucoidy, iron 366 
acquisition, amino acid metabolism, chemotaxis, cell wall/LPS/capsule synthesis and central 367 
metabolism (Table 1). The porin protein-encoding gene, oprD, had independently acquired 368 
nonsense mutations more than any other gene in the population, acquiring nonsense 369 
mutations a minimum of 32 times and carried by 51/124 genomes. A further six genomes 370 
contained larger deletions ranging from 141 bp to 647 bp (10.63% to 48.79%) within the 371 
1,326 bp oprD gene, bringing the total number of UK LES genomes with strong genetic 372 
evidence of loss of function in OprD to 57. MexA and MexB multidrug efflux pump proteins 373 
were both inferred to be adaptive by loss of function (Table 1) and are both encoded by the 374 
mexAB-oprM operon. Taken together, the genes encoding the MexAB-OprM efflux pump 375 
independently acquired loss of function mutations at least 26 times, in 50 isolates. 376 
Deficiency in DNA mismatch repair as a result of disruption to genes mutS, mutL, mutM and 377 
uvrD can result in the hypermutable phenotype, another adaptation that has been observed 378 
previously amongst P. aeruginosa CF isolates (66). In the LES dataset 10/124 genomes 379 
investigated were identified as probable hypermutators due to DNA mismatch repair 380 
deficiency. There was also evidence of cross infection of hypermutable lineages. Isolates 381 
LiP10a/b and LiP13, from two different CF patients attending the same centre, are adjacent 382 
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on the core SNP tree (Figure 2) and carry a 4 bp deletion in mutM at the same position.  In 383 
addition, isolates PHELES3 and PHELES6, also from to different patients attending the same 384 




Phylogenetic analysis of the LES 389 
Previously a limited number of LES genomes were available for comparative genomics 390 
(8,29) and studies focused on the within-host diversity and adaptation of LES lineages during 391 
chronic lung infections (65),(30). As well as greatly increasing the sample size for 392 
comparative genomics, the panel of LES isolates for this study significantly extends the 393 
geographic diversity of samples, and the diversity of associated pathologies. Using this 394 
extended dataset, we show that the LES forms a distinct clonal lineage, and that U.K. and 395 
Canadian LES isolates form distinct clades (Figure 1, Figure 2). There were two exceptions 396 
in the 145 isolate dataset, both of which were sourced in the UK but clustered with the 397 
isolates from Canada. For one (LiP6) further clinical data linked the patient with Canada. We 398 
were unable to find sufficient information to explain the location of the second (PHELES19). 399 
Nevertheless, the divergence between the isolates from Canada and UK, with the earliest 400 
known LES isolate (LESB58) lying between the groups, suggests that the LES may have 401 
established itself in both countries some decades ago and then undergone within-country 402 
spread. 403 
There were seven genes with mutations leading to amino acid substitutions in all of the clade 404 
II genomes (UK) but none of the clade I genomes (Canada), and a further gene PLES_53461 405 
with a mutation upstream in all clade II genomes.  These included genes encoding the 406 
regulatory protein NosR, a predicted two-component regulatory protein (PLES_28161), 407 
transport proteins (PLES_13941 and PLES_44581), a ring cleavage dioxygenase 408 
(PLES_44361), a putative hydroxylase (PLES_48951) and DNA gyrase (gyrB).  Loss of 409 
function mutations in genes encoding two other regulatory proteins (FleR and GltR) were 410 
also found in the majority of clade II isolates.  It is possible that some of these mutations have 411 
contributed to the adaptations allowing this strain to be transmissible.  However, if this is the 412 
case, then the spread of the clade I isolates in Canada must have been facilitated by other 413 
adaptations.  414 
There was evidence for clustering by geography within the UK. Again, there were 415 
exceptions, some of which could be explained by follow-up epidemiological investigations.  416 
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Our sample was dominated by isolates from the North West (Liverpool) region.  Notably, not 417 
all isolates from this region clustered together.  Rather, there were several separate clusters, 418 
some indicating closer relationships with isolates from other regions, consistent with some 419 
sub-lineages seeding geographical spread, followed by divergence.  It is not uncommon for 420 
CF patients to move from one area to another within the UK, and we cannot construct an 421 
entirely accurate natural history of the strain based on the limited clinical and 422 
epidemiological data available. 423 
 424 
Variations in the accessory genome content 425 
The genome of the earliest isolate of the LES (LESB58) contains large genomic islands and 426 
prophages, some of which harbour genes shown to contribute to competitiveness in an animal 427 
model of chronic infections (26,27,67).  It has also been shown that LES prophages are active 428 
as free phage in the sputum of CF patients (28). However, it is clear that LES isolates can 429 
vary in their complement of genomic islands and prophages, and also that some genomic 430 
islands and prophages were more often absent or divergent than others.  For example carriage 431 
of LES prophage 5 was restricted to sub-sets of isolates from the same CF region (Liverpool).  432 
This might support the notion that the strain first evolved in Liverpool, given that prophage 5 433 
was present in the earliest known isolate, and that loss of the unstable prophage occurred 434 
before spread, but we cannot rule out acquisition restricted to some isolates. Interestingly, 435 
absence of the most variable genomic island (GI-5) was also associated mostly with sub-sets 436 
of isolates from this same region.  In contrast, absence of GI-2 or GI-3 was rare, as was 437 
complete absence of the other LES prophages, implying that they contribute to the success of 438 
their host during chronic CF infections. In particular, genes associated with prophages 3 and 439 
4 and genomic island GI-3 featured prominently amongst those genes associated with the 440 
LES in comparison to other P. aeruginosa strains, including in prophage 3, genes putatively 441 
encoding a HicA/HicB toxin-antitoxin system, implicated in the stringent response and 442 
persistence (68). Previous studies support the notion that LES prophages contribute to the 443 
establishment of chronic lung infections (27), and our data support the idea that these 444 
accessory regions are making an important contribution to the success of the LES. It is worth 445 
noting that the isolate PHELES19, from an unusual source (blood), was also unusual in that it 446 
lacked GI-3 and most of the LES prophages.  Generally, isolates that clustered closely 447 
according to core genome SNP phylogeny tended to share the same complement of genomic 448 
islands and prophages, suggesting that instability has occurred during transmission and 449 
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spread of the LES lineage, but not so rapidly that closely-related isolates don’t broadly share 450 
the same accessory genome content. 451 
 452 
LES adaptations  453 
We identified a number of loss of function mutations previously associated with the LES. For 454 
example, fleR mutations, associated with loss of motility, a characteristic of many P. 455 
aeruginosa isolates from CF infections (69), and a defining characteristic of the LES (29), 456 
were identified in all but one of the UK isolates but not in the isolates from Canada. 457 
Although adaptations to the CF lung occurring by mutation have been widely reported (70), 458 
we also found evidence for adaptation via the loss of large genomic regions.  We identified a 459 
large region, including genes for extracellular polysaccharide (Psl), a siderophore 460 
(pyoverdine) and a type VI secretion system, that was deleted from the genomes of 15 of the 461 
LES isolates (Supplementary figure 4). The boundaries of these deletions differed between 462 
isolates, and additional, different deletions were present in some isolates, indicating the 463 
occurrence of independent deletion events and a tendency towards genome reduction during 464 
chronic infection.  Biofilm formation is considered to be an important strategy for P. 465 
aeruginosa during chronic lung infections, and the bacterium can produce three different 466 
exopolysaccharides that contribute to this process, namely Psl, Pel and alginate (71). Alginate 467 
has been strongly implicated in P. aeruginosa CF infections because of the observation that 468 
many isolates express a mucoid phenotype due to over-production of alginate because of 469 
mutations, especially in mucA (72,73).  Although the contributions of Pel and Psl during CF 470 
infections are less well understood, it has been shown that a LES isolate favours expression 471 
of pel genes over psl genes in a murine model of chronic lung infection (74).  Mutations in 472 
the pyoverdine biosynthesis genes are a common adaptation in CF, and that P. aeruginosa 473 
adapts to favour iron acquisition from haemoglobin rather than via siderophores (75,76). 474 
Hence the loss of genes encoding Psl or pyoverdine would be consistent with previous 475 
analysis of P. aeruginosa adaptions.  Since the type VI secretion system is a weapon 476 
employed by bacteria to attack competitors, loss of this system in the highly competitive 477 
multi-species environment of the CF lung is harder to understand.  However, it may be that in 478 
a biofilm lifestyle within the structurally heterogeneous environment of the CF lung, over 479 
time P. aeruginosa can establish itself in niches where there is no requirement for these 480 
weapons. 481 
We also observed many independent mutations in genes previously implicated in adaptive 482 
responses during P. aeruginosa chronic lung infections (70).  Some of these were loss of 483 
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function mutations. Mutations leading to mucoidy (mucA) or impairment of quorum sensing 484 
(lasR) are amongst the most common reported adaptations in P. aeruginosa chronic lung 485 
infections (70,77). Some of these were loss of function mutations.  We also observed 486 
common antimicrobial resistance-associated mutations, including pmrB mutations, which 487 
have been associated with adaptation to the lung in a murine chronic infection model (78). 488 
Inactivation of oprD in P. aeruginosa results in carbapenemase resistance, a growing 489 
problem with P. aeruginosa (79). Decreased expression of oprD in LES400 and LES431 490 
compared with PAO1 has been shown to correlate with an increase in minimum inhibitory 491 
concentrations (MICs) for meropenem (80). Disruptive mutations in the PAO1 mltD homolog 492 
(PA1812) have been associated with increased beta-lactam antibiotic MICs (81) and in P. 493 
aeruginosa PA14 disruptive mutations in the glpT gene result in fosfomycin resistance (82). 494 
Disruption of mpl homologs in P. aeruginosa have additionally been associated with 495 
piperacillin and ceftazidime resistance due to an accumulation of immature cell wall 496 
components and up-regulation of AmpC expression (83).  497 
The loss of the MexAB-OprM efflux pump, due to severe mutations in any of the genes in 498 
the mexAB-oprM operon, has been observed also in non-CF bronchiectasis chronic lung 499 
infections (77).  This is harder to explain in terms of an adaptation leading to antibiotic 500 
resistance.  The efflux pump has also been implicated in virulence, and it may be this 501 
alternative role that is more important in the CF lung adaptation (84).  502 
Although we have identified mutations via analysis of the genomic data, we do not here 503 
present phenotypic data to demonstrate linkage between the genetic variations and specific 504 
phenotypic adaptations. 505 
Conclusions 506 
Most CF patients acquire their P. aeruginosa from environmental sources; transmissible 507 
(epidemic) strains capable of spreading by transmission between patients are therefore 508 
unusual. Here we have demonstrated that isolates identified as the LES belong to a distinct 509 
lineage when compared to other P. aeruginosa strains and separate by core genome SNP 510 
phylogeny on the basis of country of isolation (UK or Canada). In addition to 511 
transmissibility, in both nations, the LES has been associated with greater patient morbidity 512 
(12,85).  In CF, P. aeruginosa causes long-term chronic infections, and during the course of 513 
such infections P. aeruginosa populations not only acquire adaptive mutations, but also 514 
evolve to be heterogeneous (30,70).  For our isolate collection, we cannot know how far 515 
down this adaptive process the P. aeruginosa population sampled has travelled at the point 516 
the isolate was obtained. Hence, attempts to reconstruct a global LES evolutionary history 517 
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based upon substitution rates would not yield meaningful insights. However, we observed 518 
that the oldest known isolates (LESB58, from 1988) falls between the two major clades 519 
(associated with UK or Canada), and that there are variations between the clades in terms of 520 
signature mutations and the carriage of accessory genes.  These findings suggest (a) that the 521 
LES lineage established itself separately in the UK and Canada some considerable time ago 522 
and (b) that the special characteristics of the lineage in terms of greater competitiveness, the 523 
ability to spread and associations with increased morbidity, cannot easily be assigned to 524 
shared mutations or accessory gene content. 525 
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Figure 1. Phylogenetic inference of LES genomes and 390 genomes from a previous 
study representative of the wider Pseudomonas aeruginosa population. The tree was 
constructed with IQ-TREE (43) maximum likelihood, the HKY85 substitution model and 
1000 ultra-fast bootstrap support replicates from a relaxed core fragment supermatrix (500bp 
fragments present in >=95% of genomes) with 429,463 informative sites. The tree was 
visualised by GrapeTree (48) with branches log transformed and nodes collapsed and 
coloured by MLST. MLSTs are included in the key for those represented by two or more 
genomes 
Figure 2. Phylogenetic tree inferred from core SNPs with LESB58 genomic islands and 
prophages masked. Recombinant sites determined by ClonalFrameML were excluded. The 
GTR+F+G4 substitution model was selected by IQ-TREE and there were 2,947 informative 
sites. The tree was visualised by iTol (47) with colour strip and branch colours indicating 
PHE designated regions of isolation or Canada. For visualisation branch lengths >70SNPs 
were truncated and marked with a star. Plotted around the tree is a heatmap of percent 






Fig S1. Phylogenetic approximation of the LES genomes included in this study and two 
known Pseudomonas aeruginosa phylogenetic outgroups, PAO1 and PA14. The tree was 
constructed with IQ-TREE(43) maximum likelihood, 1000 ultra-fast bootstrap supports from 
a relaxed core fragment supermatrix (500bp fragments present in >=95% genomes) with 
14,730 informative sites and rooted between known outgroups PAO1 and PA14 and the rest 
of the tree. The tree was visualised by iTol(47) with colour strip indicating PHE designated 
regions of isolation or Canada 
Fig S2. Phylogenetic tree inferred from core SNPs with LESB58 genomic islands and 
prophages masked with branch lengths shown. Recombinant sites determined by 
ClonalFrameML were excluded. The GTR+F+G4 substitution model was selected by IQ-
TREE and there were 2,947 informative sites. The tree was visualised by iTol (47) with 
colour strip and branch colours indicating PHE designated regions of isolation or Canada. 
Branch lengths shown in SNPs.  
Fig S3. LES non-redundant pairwise SNP distance histograms 
(A) Histogram of non-recombinant SNPs within clade I (primarily Canadian) and clade II 
(primarily UK) genomes exclusive pairs. (B) Histogram of exclusive pairwise SNP distances 
for SNPs for all genome pairs with and without recombinant sites removed. 
Fig S4. Deletions in genomes of LES strains.  
Deletions in genomes of LES strains. The genomes of all deletion-containing strains were 
aligned with that of LESB58. Pale grey, isolates from Liverpool; medium grey, isolates from 
elsewhere in the United Kingdom; dark grey, isolates from Canada. Isolates are listed 
sequentially from the innermost circle. The locations of deletions are listed in Table S5. The 
image was generated using BRIG. 
 
Supplementary Tables: 
Table S1. LES genomes analysed in this study.  The table includes date of isolation, if 
known, location of isolation and study source for previously sequenced isolates from either 
Winstanley et al.(26), Darch et al.(65), Williams et al.(30), Jeukens et al.(29), Dettman et 
al.(8) 




The table indicates pairwise SNP distances between all LES genomes not including 
recombinant sites  
Table S3. Genes present in >=95% of the LES genomes but <=10% of the wider 
population. Of these 108/152 are located within LESB58 genomic islands or prophages, 
particularly LES GI-3 (48 genes), LES prophage 3 (25 genes), LES prophage 4 (17 genes) 
and LES GI-1 (15 genes) 
Table S4. Genes that were present in >=95% of the wider population and <=10% of the 
LES.  
Table S5. Deletions in LES genomes.  
Table S6. Virulence factor genes in LES genomes. The presence of virulence factor genes 
was determined using Blastable (https://www.github.com/bawee/blastable) that identifies 
gene homologues using BLAST+. Some values were also confirmed using conventional 
BLAST+ 






Table 1. LESB58 genes in the UK LES population inferred to have independently 




Gene name Number of 
genomes 
Gene description 
32 oprD 51 Imipenem outer membrane porin 
18 lasR 26 Transcriptional regulator of quorum sensing 
21 mexB 43 Multidrug efflux pump transporter, part of the 
mexAB-oprM operon 
 
20 PLES_59241 32 Hypothetical membrane protein 
13 mucA 29 Anti-sigma factor for alginate biosynthesis 
10 glpT 15 Sn-glycerol-3-phosphate transporter 
9 mltD 55 Murein transglycosylase D precursor 
8 pncA 10 Nicotinamidase 
7 PLES_34011 13 TonB dependent receptor 
6 PLES_48481 16 Hypothetical protein 
6 pmrB 6 Two-component regulator system 
5 PLES_46251 12 Putative glycosyl transferase 
5 opmQ 7 Putative outer membrane protein precursor 
5 PLES_16021 5 Transcriptional regulator (marR ortholog, 
involved in repression of MDR mar operon) 
5 mpl 11 UDP-N-acetylmuramate:L-alanyl-gamma-D-
glutamyl-meso-diaminopimelate ligase 
5 chpA 5 Chemosensory system component 
5 PLES_51581 5 Putative S-adenosylmethionine decaboxylase 
proenzyme 
5 mdoH 13 Glucosyltransferase involved in biofilm 
formation 
5 ampD 111 N-acetyl-anhydromuranmyl-L-alanine 
amidase 
4 PLES_46401 101 Hypothetical protein with filamentous 
haemagglutinin outer membrane domain) 
33 
 
4 PLES_03151 9 Transcriptional regulator 
4 PLES_47771 8 Two-component sensor 
4 pchE 7 Dihydroaeruginoic acid synthase 
4 mexA 7 Multidrug efflux pump transporter, part of the 
mexAB-oprM operon 
4 PLES_07571 5 Putative oxidoreductase 
4 PLES_29121 7 Putative ATP binding/permease fusion ABC 










Figure 1. Phylogenetic inference of LES genomes and 390 genomes from a previous study representative of the wider 
Pseudomonas aeruginosa population. The tree was constructed with IQ-TREE (43) maximum likelihood, the HKY85 substitution 
model and 1000 ultra-fast bootstrap support replicates from a relaxed core fragment supermatrix (500bp fragments present in 
>=95% of genomes) with 429,463 informative sites. The tree was visualised by GrapeTree (48) with branches log transformed and 





Figure 2. Phylogenetic tree inferred from core SNPs with LESB58 genomic islands and 
prophages masked. Recombinant sites determined by ClonalFrameML were excluded. The 
GTR+F+G4 substitution model was selected by IQ-TREE and there were 2,947 informative 
sites. The tree was visualised by iTol (47) with colour strip and branch colours indicating 
PHE designated regions of isolation or Canada. For visualisation branch lengths >70SNPs 
were truncated and marked with a star. Plotted around the tree is a heatmap of percent 
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Figure 2 Click here to access/download;Figure;Fig 2.png
Fig S1. Phylogenetic approximation of the LES 
genomes included in this study and two known 
Pseudomonas aeruginosa phylogenetic outgroups, 
PAO1 and PA14. The tree was constructed with IQ-
TREE(43) maximum likelihood, 1000 ultra-fast 
bootstrap supports from a relaxed core fragment 
supermatrix (500bp fragments present in >=95% 
genomes) with 14,730 informative sites and rooted 
between known outgroups PAO1 and PA14 and the rest 
of the tree. The tree was visualised by iTol(47) with 
colour strip indicating PHE designated regions of 
isolation or Canada












































































































































































































































































































































































































































































































Fig S2. Phylogenetic tree inferred from core SNPs with LESB58 genomic islands and prophages masked with branch lengths shown. Recombinant sites 
determined by ClonalFrameML were excluded. The GTR+F+G4 substitution model was selected by IQ-TREE and there were 2,947 informative sites. The tree was 
visualised by iTol (47) with colour strip and branch colours indicating PHE designated regions of isolation or Canada. Branch lengths shown in SNPs. 
A.
B.
Fig S3. LES non-redundant pairwise SNP distance histograms
(A) Histogram of non-recombinant SNPs within clade I (primarily Canadian) and clade II 
(primarily UK) genomes exclusive pairs. (B) Histogram of exclusive pairwise SNP distances for 
SNPs for all genome pairs with and without recombinant sites removed.
Fig S4. Deletions in genomes of LES strains. 
Deletions in genomes of LES strains. The genomes of all deletion-containing strains were 
aligned with that of LESB58. Pale grey, isolates from Liverpool; medium grey, isolates from 
elsewhere in the United Kingdom; dark grey, isolates from Canada. Isolates are listed 
sequentially from the innermost circle. The locations of deletions are listed in Table S5. The 
image was generated using BRIG.
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